Behavioral and neurochemical effects induced by chronic L-DOPA administration

Pharmacology Biochemistry and Behavior

Volumn 54, Issue 4, 1996, Pages 779-785

  Molinengo, Luigi ^a   Scordo, Isabella ^a   Pastorello, Barbara ^a   Orsetti, Marco ^a   Ghi, Piera ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Cholinergic system; Chronic administration; Dopaminergic system; L Dopa plus benserazide; Memory storage; Noradrenergic system; Serotoninergic system; Staircase maze

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ATROPINE; BENSERAZIDE PLUS LEVODOPA; DOPAMINE; MUSCARINIC RECEPTOR; NORADRENALIN; PRAZOSIN; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CHOLINERGIC SYSTEM; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; HIPPOCAMPUS; LOCOMOTION; MALE; MAZE TEST; MEMORY; MONOAMINE METABOLISM; NONHUMAN; NORADRENERGIC SYSTEM; OLFACTORY SYSTEM; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SEROTONINERGIC SYSTEM;

ANIMALIA;

EID: 0030218846     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-3057(95)02227-9     Document Type: Article

References (36)

1. 1. Altman, H. J.; Quartermain, D. Facilitation of memory retrieval by centrally administered catecholamine stimulating agents. Behav. Brain Res. 7:51-63; 1983.
2. 2. Bartholini, G.; Da Prada, M.; Pletscher, A. Decrease of cerebral 5-hydroxytryptamine by 3,4-dihydroxyphenylalanine after inhibition of extracerebral decarboxylase. J. Pharm. Pharmacol. 20:228-229; 1968.
3. 3. Bartholini, G. Interaction of striatal dopaminergic, cholinergic and GABA-ergic neurons: Relation to extrapyramidal function. Trends Pharmacol. Sci. 1:138-140; 1989.
4. 4. Beani, L.; Bianchi, C. The extraction of acetylcholine in small samples of cerebral tissue. J. Pharm. Pharmacol. 15:281-282; 1963.
5. 5. Butcher, L.; Engel, J.; Fuxe, K. L-DOPA induced changes in central monoamine neurons after peripheral decarboxylase inhibition. J. Pharm. Pharmacol. 22:313-316; 1970.
6. 6. Carey, R. J. Chronic L-DOPA treatment in the unilateral 6-OHDA rat: Evidence for behavioral sensitization and behavioral tolerance. Brain Res. 568:205-214; 1991.
7. 2 receptors. Behav. Neural. Biol. 56:283-291; 1991.
8. 8. Christie, J. E.; Shering, A.; Ferguson, J.; Glen, I. M. Physostigmine and arecoline: Effects of intravenous infusion in Alzheimer presenile dementia. Br. J. Psychiatry 138:46-50; 1981.
9. 9. Ehrenstrom, F.; Johansson, P. A method for very rapid determination of catechols using ion-pairing reverse phase electrochemical detection: Effects of L-DOPA treatment on catechol content in various brain structures. Life Sci. 36:867-879; 1985.
10. 10. Everett, G. M.; Borchherding, J. W. L-DOPA effect on concentration of dopamine, norepinephrine, and serotonin in brains of mice. Science 168:849-850; 1970.
11. 11. Flood, J. F.; Landry, D. W.; Jarvik, M. E. Cholinergic receptor interactions and their effects on long term memory processing. Brain Res. 215:177-185; 1981.
12. 12. Flood, J. F.; Smith, G. E.; Gherkin, A. Memory retention: Potentiation of cholinergic drug combination in mice. Neurobiol. Aging 4:37-43; 1983.
13. 13. Flood, J. F.; Smith, G. E.; Gherkin, A. Memory retention test performance in mice: Improvement by chronic oral cholinergic drug treatment. Pharmacol. Biochem. Behav. 21:169-173; 1984.
14. 14. Flood, J. F.; Smith, G. E.; Gherkin, A. Memory enhancement in mice: Role of drugs dose and training-testing interval. Pharmacol. Biochem. Behav. 29:635-639; 1988.
15. 15. Glossmann, H.; Hornung, R. α adrenoceptors in rat brain: Sodium changes the affinity of agonists for prazosin sites. Eur. J. Pharmacol. 61:407-408; 1980.
16. 16. Izquierdo, I. Mechanism of action of scopolamine as an amnestic. Trends Pharmacol. Sci. 10:175-177; 1989.
17. 17. Johnson, R. D.; Iuvone, P. M.; Minneman, K. P. Regulation of alpha-1 receptor density and functional responsiveness in rat brain. J. Pharmacol. Exp. Ther. 242:842-849; 1987.
18. 18. Keller, R.; Oke, A.; Mefford, I.; Adams, R. N. Liquid Chromatographic analysis of catecholamines routine assay for regional brain mapping. Life Sci. 19:995-1004; 1976.
19. 19. Levin, E. D.; McGurk, S. R.; Rose, J. E.; Butcher, L. L. Cholinergic-Dopaminergic interactions in cognitive performance. Behav. Neural. Biol. 54:271-299; 1990.
20. 2 interactions with nicotinic and muscarinic systems for working memory. In: Levin, D. E.; Decker, M. W.; Butcher, L. L., eds. Neurotransmitter interactions and cognitive function. Boston: Birkhäuser; 1992: 144-158.
21. 21. Lowry, O. H.; Rosenbrough, N. J.; Farr, A. L.; Randall, R. J. Protein measurement with Folin phenol reagent. J. Biol. Chem. 193:265-275; 1951.
22. 22. Melamed, E.; Globus, M.; Friedlender, E.; Rosenthal, J. Chronic L-DOPA administration decreases striatal accumulation of dopamine from exogenous L-DOPA in rats with intact nigrostriatal projections. Neurology 33:950-953; 1983
23. 23. Molinengo, L.; Ghi, P.; Oggero, L. Orsetti, M. Behavioral and neurochemical modifications caused by chronic alpha-methylparatyrosine administration. Pharmacol. Biochem. Behav. 39:437-442; 1991.
24. 24. Molinengo, L.; Orsetti, M.; Ghi, P.; Pastorello, B. Action of chronic choline administration on behavior and on cholinergic and noradrenergic systems. Pharmacol. Biochem. Behav. 44:587-594; 1993.
25. 25. Molinengo, L.; Oggero, L.; Ghi, P.; Orsetti, M. Action of chronic disulfiram administration on memory decay and on central cholinergic and adrenergic system. Brain Res. 551:72-77; 1991.
26. 26. Molinengo, L. The action of scopolamine on retrieval and memory storage in rats evaluated in the staircase maze. Behav. Neural. Biol. 59:18-24; 1993.
27. 27. Molinengo, L.; Orsetti, M.; Pastorello, B.; Scordo, I.; Ghi, P. The action of arecoline on retrieval and storage evaluated in the staircase maze. Neurobiol. Learn. Memory 63:167-173; 1995.
28. 28. Ng, K. Y.; Chase, T. N.; Colburn, R. W.; Kopin, I. J. L-DOPA-induced release of cerebral monoamines. Science 170:76-77; 1970.
29. 29. Packard, M. G.; White, N. M. Memory facilitation produced by dopamine agonist: Role of receptor subtype and mnemonic requirements. Pharmacol. Biochem. Behav. 33:511-518; 1989.
30. 30. Ponzio, F.; Cimino, M.; Achilli, G.; Lipartiti, M.; Perego, C.; Vantini, G.; Algeri, S. In vivo and in vitro evidence of dopaminergic system down regulation induced by chronic L-DOPA. Life Sci. 34:2107-2116; 1984.
31. 31. Quartermain, D.; Judge, M. E.; Leo, P. Attenuation of forgetting by pharmacological stimulation of aminergic neurotransmitter systems. Pharmacol. Biochem. Behav. 30:77-81; 1988.
32. 32. Stadler, H.; Lloyd, K. G.; Gadea-Ciria, M.; Bartholini, G. Enhanced striatal acetylcholine release by chlorpromazine and its reversal by apomorphine. Brain Res. 55:476-480; 1973.
33. 2 receptor activation during the posttraining period improves memory for visual or olfactory conditioned responses in rats. Behav. Neural Biol. 55:255-269; 1991.
34. 34. White, N. M.; Packard, M. G.; Seamans, J. Memory enhancement by posttraining peripheral administration of low doses of dopamine agonist: Possible autoreceptor effect. Behav. Neural Biol. 59:230-241; 1993.
35. 35. Yamamura, H. L.; Snyder, S. H. Muscarinic cholinergic binding in rat brain. Proc. Natl. Acad. Sci. USA 71:1725-1729; 1974.
36. 36. Zis, A. P.; Fibiger, H. C.; Phillips, A. G. Reversal by L-DOPA of impaired learning due to destruction of the dopaminergic nigroneostriatal projection. Science 185:960-962; 1974.